Newborn screening for epilepsy in sight through the discovery of novel disease biomarkers

(Radboud University Nijmegen) The door has finally opened on screening newborn babies for pyridoxine-dependent epilepsy (PDE), a severe inherited metabolic disorder. This screening promises to enable better and earlier treatment of the disease. To identify new biomarkers that can be used in the newborn screening protocol, also known as the neonatal heel prick, researchers at the Radboud University Medical Center joined forces with scientists at the Radboud University's FELIX laser laboratory.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news